Literature DB >> 33751548

Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.

Paul Deschamps1,2, Mufaddal Moonim1,3, Deepti Radia1, Natalia Curto-Garcia1, Claire Woodley1, Sarah Bassiony1, Jennifer O'Sullivan1, Patrick Harrington1, Kavita Raj1, Yvonne Francis1, Shahram Kordasti1,4, Sahra Ali1, Claire N Harrison1, Donal P McLornan1.   

Abstract

Myeloproliferative neoplasm-unclassifiable (MPN-U) presents an MPN-type phenotype that fails to meet diagnostic criteria for other MPN variants. Variability in the clinicopathological phenotypes presents many challenges. Amongst a registry cohort of 1512 patients with MPN, 82 with MPN-U were included, with a median (range) age of 49·7 (13-79) years. Albeit heterogeneous, common presentation features included raised lactate dehydrogenase, thrombocytosis and clustered/pleomorphic megakaryocytes on trephine biopsy. Thrombosis was common (21%), necessitating vigilance. The median event-free survival was 11·25 years (95% confidence interval 9·3-not reached), significantly shortened in cases with lower platelet counts (<500 × 109 /l) and a leucocytosis (≥12 × 109 /l) at presentation. Generation of potential MPN-U prognostic scores is required.
© 2021 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical data; genomics; myeloproliferative neoplasms-unclassifiable; outcome

Year:  2021        PMID: 33751548     DOI: 10.1111/bjh.17375

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  1 in total

1.  Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.

Authors:  Fulvia Pimpinelli; Francesco Marchesi; Giulia Piaggio; Diana Giannarelli; Elena Papa; Paolo Falcucci; Martina Pontone; Simona Di Martino; Valentina Laquintana; Antonia La Malfa; Enea Gino Di Domenico; Ornella Di Bella; Gianluca Falzone; Fabrizio Ensoli; Branka Vujovic; Aldo Morrone; Gennaro Ciliberto; Andrea Mengarelli
Journal:  J Hematol Oncol       Date:  2021-05-17       Impact factor: 17.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.